Evidence map›Paper›PMID 30274258›Full record

ArticleProteomes2018

Fyn Regulates Binding Partners of Cyclic-AMP Dependent Protein Kinase A.

Anna M Schmoker, Samuel A Barritt, Marion E Weir, Jacqueline E Mann, Tyler C Hogan, Bryan A Ballif, Paula B Deming

Open access · goldAbstract read
In one paragraph

Article in Proteomes, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.2field-weighted citation impact, top 46% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 12 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Anna M SchmokerDepartment of Biology, University of Vermont, Burlington, VT 05405, USA. aschmoke@uvm.edu.
Samuel A BarrittDepartment of Biology, University of Vermont, Burlington, VT 05405, USA. sbarritt@g.harvard.edu.
Marion E WeirDepartment of Biology, University of Vermont, Burlington, VT 05405, USA. marion.weir@cellsignal.com.
Jacqueline E MannDepartment of Biomedical and Health Sciences, University of Vermont, Burlington, VT 05405, USA. jacmann@umich.edu.
Tyler C HoganDepartment of Biomedical and Health Sciences, University of Vermont, Burlington, VT 05405, USA. Tyler.Hogan@uvm.edu.
Bryan A BallifDepartment of Biology, University of Vermont, Burlington, VT 05405, USA. bballif@uvm.edu.
Paula B DemingDepartment of Biomedical and Health Sciences, University of Vermont, Burlington, VT 05405, USA. paula.deming@med.uvm.edu.
University of Vermont · US

Funding

Vermont INBRE Administrative Supplement 2024 AWD 118P20GM103449 · NIGMS · UNIVERSITY OF VERMONT & ST AGRIC COLLEGE · PI CHRISTOPHER S FRANCKLYN · 2012 to 2026
$58.4M
NIH HHS 8P20GM103449
6 · The paper itself

Abstract

The cAMP-dependent protein kinase A (PKA) is a serine/threonine kinase involved in many fundamental cellular processes, including migration and proliferation. Recently, we found that the Src family kinase Fyn phosphorylates the catalytic subunit of PKA (PKA-C) at Y69, thereby increasing PKA kinase activity. We also showed that Fyn induced the phosphorylation of cellular proteins within the PKA preferred target motif. This led to the hypothesis that Fyn could affect proteins in complex with PKA. To test this, we employed a quantitative mass spectrometry approach to identify Fyn-dependent binding partners in complex with PKA-C. We found Fyn enhanced the binding of PKA-C to several cytoskeletal regulators that localize to the centrosome and Golgi apparatus. Three of these Fyn-induced PKA interactors, AKAP9, PDE4DIP, and CDK5RAP2, were validated biochemically and were shown to exist in complex with Fyn and PKA in a glioblastoma cell line. Intriguingly, the complexes formed between PKA-C and these known AKAPs were dependent upon Fyn catalytic activity and expression levels. In addition, we identified Fyn-regulated phosphorylation sites on proteins in complex with PKA-C. We also identified and biochemically validated a novel PKA-C interactor, LARP4, which complexed with PKA in the absence of Fyn. These results demonstrate the ability of Fyn to influence the docking of PKA to specific cellular scaffolds and suggest that Fyn may affect the downstream substrates targeted by PKA.

Indexed as

AKAPsbinding partnerscentrosomeFynGolgi apparatusLARP4mass spectrometryprotein kinase ASILAC

Identifiers

PMID30274258
PMCPMC6313912
OpenAlexW2893233801

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.